Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Details for Australian Patent Application No. 2012202668 (hide)

Owner Dana-Farber Cancer Institute, Inc. The General Hospital Corporation

Inventors Bell, Daphne Winifred; Haber, Daniel A.; Janne, Pasi Antero; Johnson, Bruce E.; Lynch, Thomas J.; Meyerson, Matthew; Paez, Juan Guillermo; Sellers, William R.; Settleman, Jeffrey E.; Sordella, Raffaella

Agent Pizzeys

Pub. Number AU-A-2012202668

Parent 2007202288

Filing date 8 May 2012

Wipo publication date 31 May 2012

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

24 May 2012 Complete Application Filed

31 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202668

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202669-Access port

2012202667-Trench Drainage System